Rybrevant SC 1600 mg/10 ml
Rybrevant SC 1600 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 69839. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 28 January 2026 and the authorisation is limited until 27 January 2031. ATC code L01FX18 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69839 |
|---|---|
| Name | Rybrevant SC 1600 mg/10 ml |
| Full name | Rybrevant SC 1600 mg/10 ml, Injektionslösung |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX18 |
| First authorisation | 28 January 2026 |
| Authorisation validity | 27 January 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rybrevant SC 1600 mg/10 ml, Injektionslösung | A | 28 January 2026 |
| 2 | Rybrevant SC 2240 mg/14 ml, Injektionslösung | A | 28 January 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FX18 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FX18 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rybrevant SC 1600 mg/10 ml authorised in Switzerland?
Yes. Rybrevant SC 1600 mg/10 ml is authorised by Swissmedic under authorisation number 69839, data as of 01 September 2026. The authorisation is limited until 27 January 2031.
Which dispensing category does Rybrevant SC 1600 mg/10 ml have?
Rybrevant SC 1600 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Rybrevant SC 1600 mg/10 ml?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.